The move comes as the whole agriculture industry, co-ordinated by agricultural and food industry alliance RUMA (which promotes responsible use of medicines in farming), looks to build on the recent 10% reduction in use of antibiotics to treat farm animals.
The BCVA’s Dr Elizabeth Berry, who prepared the recommendations, said that whilst the responsible use of antibiotics has been promoted for many years across farming sectors, there is still the potential to reduce use in some areas and to move away from products which are important for human health.
She said: "This is an official position from BCVA to our members but we would like to see all in the cattle sectors embrace these recommendations in the understanding that we need to play our part in increasing responsible use of antibiotics.
"Work still needs to be done to establish the levels currently being used in cattle so that appropriate targets can be set but there are measures that can immediately be adopted.
"So we are recommending reducing both the overall amount of antibiotics used in cattle practice and minimising the use of the high priority CIAs – namely third and fourth generation cephalosporins, fluoroquinolones and colistin. These drugs should only be used where they have been demonstrated by sensitivity testing to be the only suitable choice to avoid unnecessary suffering."
The BCVA, which has over 1,100 practising members covering around 85% of vets working with cattle, is also recommending that use of antibiotics as a preventative treatment is avoided wherever possible as long as animal welfare is not compromised.
Dr Berry added: "Where preventative treatment – or prophylaxis – is used it should be regarded as an interim measure whilst alternative management or vaccination strategies are implemented.
"For example, all cows which comply with recommendations for using an internal teat sealant should be considered for non-antibiotic treatments at drying off."
The BCVA continues to advise that every farm should have a herd health plan which embraces all of the disease control strategies appropriate for disease reduction on that farm. In addition, farm management best practice should be followed, such as the guidelines issued by Red Tractor farm assurance.
Dr Berry says BCVA further recommends that all herds should establish their BVD status and eradicate the disease where it is found. "BVD can have a detrimental effect on incidence of many diseases and its eradication will have a significant impact on the need for antimicrobial use.
"We also continue to recommend the use of diagnostics to identify disease so that appropriate treatments can be selected and vaccination programmes instituted to prevent or reduce the severity of disease."
BCVA’s confirmation of its official position has been welcomed by RUMA. Secretary General John FitzGerald says that while RUMA’s promotion of responsible use over the past 20 years means the UK remains among the lower users of antibiotics in farming in Europe1, more needs to be done.
"The BCVA’s position is clear and leaves no doubt that action needs to be taken,” says Mr FitzGerald. “It is underpinned by science, recognising that banning preventative use outright or access to critically important antibiotics is not an answer. Both are important tools in fighting disease and preventing suffering so we still need them – but we need to use them more strategically and only when no other options exist."
The complete list of guidelines can be downloaded from the BCVA website www.bcva.eu.
Julian said: "People are turning to surgeries where there are more cats, dogs and rabbits, as there is a general perception that a small animal job is easier. There are often less out-of-hours complaints, you don’t have the 2am cow to calve and you don’t have to spend three hours in the mud and rain.
"In mixed practice, you have stretches of 19 days without a day off and 11 nights on call, rain lashing down. People don’t want to do that any more."
He added that a few years ago, there would have been 50 applicants for a job at the Skeldale Veterinary Centre, whereas a recent advertisement drew just 10.
Responding in a Facebook post, Danny Chambers MRCVS, an equine locum vet who has worked in mixed practice at E.C. Straiton & Partners, argues that the problem isn't a lack of enthusiasm amongst new grads for working in mixed practice, but that: "...any practice that expects people to work those types of hours for that level of income with minimal support should consider themselves lucky to get even 10 applications for a position."
The responsible use of antibiotics termed critically important is an important strand in the UK policy to fight antibiotic resistance development.
However, NOAH says there is much confusion about which antibiotics should be considered within this group, with different organisations referring to different classes.
Donal Murphy, Head of Technical and Regulatory Affairs at NOAH said: "NOAH believes the classification and use of antibiotics in veterinary medicine should be driven and guided by the regulators, who are independent and make science based decisions and recommendations.
"Of course, all classes of antibiotics, whether critically important or not, should be used responsibly and guided by the principle outlined by the Responsible Use of Medicines in Agriculture Alliance (RUMA) who state they should be used 'as little as possible but as much as necessary'. The use of these important products in this manner can ensure that the availability and efficacy of antibiotics can be maintained to ensure animal health and welfare in the future."
You can download the briefing document here.
Containing ceftiofur (50mg/ml) and ketoprofen (150mg/ml), Curacef Duo is presented in a ready-to-use suspension for injection at a low volume dosage – 1 ml/50kg – which is identical to short-acting ceftiofur alone.
Virbac says that Curacef Duo’s combined action can help to minimise production losses in calves and offer a quick return to production for dairy cows affected by bacterial BRD. It can also improve welfare by targeting infection, inflammation and pain all at once, while its ease of use and simple dosing help to increase compliance. Curacef Duo offers a zero milk withdrawal period and an eight day withdrawal period in meat.
Brigitte Goasduf MRCVS, Large Animal Product Manager at Virbac, said: "In creating the first 'two-in-one' combination of two tried and trusted actives, the antibiotic ceftiofur and NSAID ketoprofen, we are offering practitioners an alternative to the treatment of bacterial BRD.
"We believe that the benefits Curacef Duo offers in terms of efficacy, ease of use and action on inflammation and pain, will be valued by both practitioners and farmers."
Reporter Andy Davies spoke to Charlotte Debbaut MRCVS, a veterinary surgeon from Belgium working at the Tindale Veterinary Practice in Gloucestershire, where there are 13 vets with eight different nationalities. He also interviewed Matthew Pugh MRCVS and Ovidiu Oltean MRCVS from Belmont Veterinary Centre, a mixed practice in Hereford which employs five foreign nationals out of a team of 13 veterinary surgeons.
Finally, he talked to John Blackwell MRCVS at Brownlow Veterinary Group in Shropshire, where Brexit had already caused a Croatian member of his team to refuse a permanent position and return to Ireland.
Congratulations to the RCVS and BVA press offices, who will have been hard at work behind the scenes.
See: https://www.channel4.com/news/brexit-affecting-vet-recruitment
The BVA has expressed its disappointment at a report instructed by the Welsh Government that recommends CCTV should not be mandatory in slaughterhouses in Wales.
The Safeguarding Animal Welfare at Slaughter Task and Finish Group’s report, which outlines the findings of the Group’s investigation into the welfare of animals in slaughterhouses and the potential role of CCTV, concluded that there was not a "sufficient basis" for making CCTV in Welsh abattoirs mandatory.
The BVA and the Veterinary Public Health Association (VPHA) believe mandatory CCTV in slaughterhouses and veterinary surgeons' unrestricted access to CCTV footage are vital in order to safeguard animal welfare, assist with enforcement and instil customer confidence.
Dr Neil Paton, BVA Welsh Branch President, said: "We are disappointed that the Task and Finish Group has not taken on board the concerns of vets working in slaughterhouses and not followed the logic of their own arguments about the benefits of CCTV highlighted in the report. While we know that CCTV is not the answer to all welfare concerns, it is recognised as an important tool by the Farm Animal Welfare Committee and encourages the highest standards of animal welfare and good stockmanship. We also need to ensure that where CCTV is installed, vets can have access to the footage. If there isn’t CCTV footage, or vets cannot access the footage, how can the number of reported incidents in abattoirs be verified?"
The report, The Need for and Possible Implementation of a Workable System of CCTV in All Slaughterhouses in Wales, details that only eight large abattoirs of the total 26 abattoirs in Wales have CCTV. Although the bulk of animals in Wales are slaughtered in these eight abattoirs, lack of CCTV in other abattoirs means 3.4% of poultry are slaughtered without CCTV safeguards, accounting for over 2 million birds, and 10.5% of sheep, pigs and cattle are slaughtered in abattoirs without CCTV – nearly 385,000 animals. The potential risk of welfare harm to these animals is increased by this lack of CCTV.
Gudrun Ravetz, President of the British Veterinary Association said: "What vets who work in slaughterhouses, and all those who care about animal welfare, are striving for is a culture of compassion in abattoirs. CCTV is an important tool in encouraging and implementing such a culture. The report’s recommendations encourage abattoirs to install and use CCTV effectively for training purposes, but, together with the VPHA, we would like to re-emphasise our calls for CCTV to be mandatory in all slaughterhouses in the UK and for legislation to ensure that footage is readily available to vets. We recognise that the cost of installing CCTV may be a burden for some very small abattoirs, but it is important that the animals we farm for food have both a good life and a humane death and CCTV has a key role to play in ensuring these requirements are met."
The report also outlined a number of other recommendations, which are welcomed by BVA, including the request for grants to be made available to assist small sites invest in the equipment and an additional focus on the improvement of welfare of animals during transport to slaughter.
The Department for Environment, Food and Rural Affairs (Defra) says this is evidence that its strategy to tackle bovine TB, which costs taxpayers £100m a year, is delivering results.
Defra says that gaining OTF status for the low risk area, covering the north and east of England, would boost trade opportunities and mean some herds require less regular TB testing, reducing costs for farmers.
This would be the first time anywhere in England has enjoyed this status and the government says it is a key step in its 25-year plan for the whole of the UK to be TB-free by 2038.
Environment Secretary Andrea Leadsom said: "Gaining global recognition that more than half of England is TB-free will be a significant milestone in our long-term plan to eradicate this devastating disease, and will open up new trading opportunities for farmers.
"We have much still to do in the worst affected parts of the country, but this shows that our strategy - combining practical biosecurity measures, a robust cattle movement and testing regime, and badger control in areas where the disease is rife - is right and is working."
Results published today confirm all ten licensed badger control operations achieved successful outcomes. A consultation opens today on next steps for badger control in areas that have completed the first four years of intensive culling.
Other measures announced today include:
Chief Veterinary Officer Nigel Gibbens said: "This year we have seen that badger control can be delivered successfully on a wider scale. Further expansion in the coming years, alongside our robust cattle movement and testing regime, will allow us to achieve and maintain long term reductions in the level of TB across the South West and Midlands where the disease is currently widespread."
The government says it is taking robust action to make the country TB-free by 2038, with a strategy including stronger cattle testing and movement controls, good biosecurity, badger control in areas where TB is rife and vaccination when possible.
Vaccinating healthy badgers is part of the government’s long-term plan and could play an important role in preventing bovine TB spreading to new areas of the country. Defra plans to resume the Badger Edge Vaccination Scheme, which offers support for private badger vaccination projects in edge area counties, in 2018 when we expect vaccine supplies to be available once more following the current global shortage.
The government is also supporting farmers to take practical action to reduce the risk of infection onto their farm. This includes support for a new CHeCS TB cattle herd accreditation scheme, on-farm biosecurity demonstrations for farmers, and training for veterinary surgeons delivered by APHA jointly with the private sector. Farmers can also access practical guidance on the TB Hub, which brings advice from farming experts, vets and government together in one place.
Homeopathy is widely used in livestock, especially to replace or reduce the use of antibiotics in the treatment of infectious diseases, although its use is often seen as controversial. For organic agriculture, homeopathy is even promoted.
In the review, Dr Caroline Doehring and Professor Albert Sundrum from the University of Kassel, Germany, assessed peer-reviewed studies on the efficacy of homeopathy in cattle, pigs and poultry published between 1981 and 2014.
They analysed a total of 52 clinical trials, 34 with cattle, 12 with pigs and six with poultry. They were published in 48 publications.
Of these, 28 concluded that the homeopathic remedy administered was effective, 22 showed no efficacy and 2 were inconclusive.
Only 10 trials provided information on cure rates for the treatments. These varied to a high degree, while the remedy used did not seem to make a big difference.
Trials on pigs were frequently efficacious, while studies with cattle or poultry had a similar distribution of efficacious and non-efficacious treatment.
Double-blind randomised controlled trials reported efficacy of the homeopathic treatment almost as often as they reported lack of it.
Meanwhile, single-blind and non-blind randomised controlled trials, and observational trials were more likely to present evidence of efficacy, suggesting that positive outcomes may be due to bias.
Other study limitations, such as potential conflict of interests, low sample size, risk for selective reporting and bias, were found in the majority of trials.
While some clinical trials showed effectiveness, the authors of the review question the reliability of the evidence, because all studies had a range of limitations. For example, all clinical trials were conducted under very specific conditions and none were repeated under comparable conditions.
Therefore, the authors say the findings cannot be be used to recommend homeopathy: "The current evidence of studies providing evidence in favour of homeopathy lacks reproducibility and therefore cannot claim to have sufficient prognostic validity."
"Due to a lack of prognostic validity, replacing or reducing antibiotics with homeopathy currently cannot be recommended unless evidence of efficacy is reproduced by RCTs and proven in various farm practice conditions."
The voluntary scheme, which has been welcomed by Farming Minister George Eustice and Welsh Government Cabinet Secretary for Environment and Rural Affairs Lesley Griffiths, improves a herd’s ‘score’ every year it is free from a bTB breakdown, awarding a status of 0-10.
This new bTB scheme will require the herd vet and cattle owner to work together on following a number of biosecurity measures already successfully implemented in five other cattle disease control programmes.
As well as reducing risk of infection, the country-wide programme could present informed purchasing opportunities. In particular, it could benefit farmers selling cattle from regions with a high risk of the disease or who wish to minimise exposure from bought-in animals. It could also give recognition for a farmer’s efforts to complement Government and industry strategies to control infection.
Farming Minister George Eustice (pictured left above, with BCVA President Andrew Cobner) said: "Dealing with Bovine TB is costing us £100 million a year and causing devastation and distress for farmers and rural communities across the country. 33,000 cattle were slaughtered because of the disease last year alone and many farms are subject to movement restrictions which can affect their trade.
"But we know some 40% of herds in the high-risk area in England have never had a breakdown, and the CHeCS scheme will help them to communicate this so they can carry out risk-based trading to support their businesses.
"The scheme will also recognise those practicing good biosecurity, which is a core part of our long-term plan to tackle bovine TB."
The scheme complements the Government’s 25-year plan to eradicate Bovine TB in England, and will provide another tool for farmers who want to show they are following best practice. It follows the launch of the TB Hub (www.tbhub.co.uk), which offers practical advice and guidance as well as background into the disease.
The Cabinet Secretary, Mrs Griffiths, said: "The Welsh Government has been supportive of this initiative from the start. By focusing on individual herds, the scheme complements our proposed regional approach, for example those herds in the high TB areas which have not recently had TB will be able to demonstrate they are a lower risk.
"This industry-led initiative aimed at reducing TB is to be welcomed and fits in with our principles of working in partnership and promoting the benefits of disease prevention. I urge Welsh farmers to engage with the scheme and reduce the risk of disease being introduced into their herd."
Across Great Britain, CHeCS has over 14,000 member herds, representing around 14% of cattle holdings in some form of monitoring, control and eradication of disease.
Keith Cutler, CHeCS board member and partner in the Endell Veterinary Group, said: "CHeCS so far has focused on control of non-statutory diseases – Johne’s Disease, IBR, BVD, Leptospirosis and Neospora. Participating health schemes have been monitoring the health status of participating herds for some years.
"With this programme, we will be working with Government to receive official TB test data with the agreement of the farmer. It’s an exciting development for CHeCS, but there is a natural fit because of the expertise CHeCS-accredited health schemes already have with monitoring biosecurity measures on their members’ farms."
Andrew Cobner, president of the British Cattle Veterinary Association, who has been technical lead on the project since the start, said: "All too often we are confronted with the view that there is little or nothing that we can do to control TB. We wouldn’t accept this attitude with any other infectious disease so it’s time farmers and vets fought back. We have a government that is willing to embrace all of the measures necessary and we have a 25 year plan in place. Part of this will involve increasing biosecurity and risk-based trading, and CHeCS is leading the way."
The CHeCS bTb Herd Accreditation scores run from 0 (following all CHeCS measures but had a herd breakdown within the past 12 months), to 1 (following CHeCS measures and one year since the last herd breakdown) all the way though to 10 (following CHeCS measures and 10 years or more since the last herd breakdown).
Veterinary surgeons who think their clients might want to know more can point them in the direction of: www.checs.co.uk to read the technical standard, programme handbook and Q&A. If it sounds advantageous to their farm, they should discuss joining with you, then contact one of the participating CHeCS-accredited health schemes listed on the website. The application form includes a privacy agreement to allow the Animal and Plant Health Agency (APHA) to send test data automatically to the health scheme, and a declaration from the herd vet. After the form is sent back, a starting score will be awarded.
More information on bTB is also available at www.tbhub.co.uk.
This third biennial offering from GB’s Cattle Health and Welfare Group also contains a summary of progress on endemic disease control with advances in eradicating Bovine Viral Diarrhoea (BVD) in each country highlighted.
The Chief Veterinary Officers of UK, Scotland and Wales have welcomed the publication of the report saying that as the possible impacts of the referendum on leaving the EU are considered, the importance of a GB focus on disease control is as important as ever.
In their joint forward, Nigel Gibbens, Sheila Voas and Christianne Glossop said: "The healthier our animals, the more attractive our products. The better our animal welfare, the greater the confidence of consumers in our production systems.
"With the UK Government placing AMR at the top of its risk register alongside terrorism and pandemic ’flu, it is heartening to see that CHAWG, in common with other livestock sectors, has grasped the nettle in looking first at how the cattle sector can better capture data on use of antimicrobials."
They go on to say that addressing AMR helps address other imperatives as an emphasis on sound animal husbandry and healthy animals kept to high welfare standards will help minimise routine reliance on antimicrobials: "Success in controlling endemic disease is one area of considerable importance, and here we can highlight CHAWG’s pivotal role in the development and promotion of national disease control programmes. These include the launch of the BVDFree scheme in England earlier this year, ongoing progress with BVD eradication in Scotland, the development of a Wales BVD scheme, and the Action Johne’s initiative."
In the report’s conclusion, RSPCA’s head of farm animals Marc Cooper points out that it is clear many positive initiatives are being pursued within the industry. He said: "Notable amongst these are those associated with dairy cow genetics, eliminating BVD, the national dairy cow welfare strategy and the development of a data hub for the collation of information relating to antimicrobial use.
"Indeed, some of these are starting to realise improvements in key areas, for example, dairy cow longevity is beginning to increase, and cow fertility figures and somatic cell counts appear to be moving in the right direction.
"However, there are still ongoing concerns relating to some important health and welfare issues. For example, despite the evidence suggesting the annual prevalence levels of cattle lameness are beginning to fall, there still appears to be no centralised database for recording it."
Chairman of CHAWG Tim Brigstocke says the contributed comments are encouraging and provide positive direction for future CHAWG activities. He also reassures that while this report sees a number of advances in highly topical areas, ‘core’ activities are not being ignored. He said: "Effective farm health planning remains the bedrock of good practice. And while we tend to focus on areas which need improvement, it’s worth mentioning that a delegation from the Food & Veterinary Office (FVO) of the European Commission recently visited and were impressed by the coordinated approach taken in this country."
The report can be downloaded from www.chawg.org.uk.
The app gives users the ability to find information on over 1000 animal medicine listings included on the compendium website; with the complete datasheets available for viewing.
The new app also allows you to scan datamatrix barcodes on veterinary medicinal product packaging to take you straight to important product information. You can also search by medication, manufacturer or GTIN.
Dawn Howard, NOAH’s Chief Executive said: "The NOAH Compendium is the recognised industry reference, and it is essential we fully utilise the information offered in the compendium with modern technology, whilst protecting the integrity and respect that it holds.
"The website, which we relaunched earlier this year, has had over 8.5 million views to date. We feel this app serves as a great addition to this modern method of accessing data – meaning users are no longer reliant on internet access to obtain the information they need.
"As an organisation, we will continue to embrace new technologies to ensure animal medicine is used correctly and responsibly in the UK. The launch of this new app goes towards ensuring all those who prescribe or use animal medicines have access to the latest technical information available for companion and farm animals when they need it."
The founders of ioLight, Andrew Monk and Richard Williams, will be in attendance on the Bayer stand to answer questions about the new product.
James Crawford, Head of Marketing at Bayer, said: "Bayer is delighted to present the ioLight microscope on our stand at the London Vet Show 2016. The microscope provides fantastically clear images and is simple to use, showing off Bayer's products for all our customers to see."
Professor Mike Taylor, a Diplomate of the European Veterinary Parasitology College, is in the process of evaluating the ioLight microscope as a tool for the diagnosis of parasitic infections of farm animals.
Normally he uses a laboratory microscope for this work but they are not routinely used on a farm. He has also tried a portable digital microscope, but finds it does not give the resolution required for identification of protozoan parasite species or for counting nematode eggs. Mike said: "The ioLight’s portability, image quality and connectivity to the Apple iPad offer great potential for the development of rapid methods for identifying parasites, or determining parasite burdens. I can envisage its use by both veterinarians and suitably trained livestock farmers, in the practice laboratory or directly on the farm."
Andrew Monk said: "Since our launch earlier this year we have seen a massive interest from the veterinary sector. We are thrilled to have the opportunity to demonstrate our microscope to such a large audience, and are looking forward to working with Bayer."
For more information visit iolight.co.uk or email Andrew Monk at andrew.monk@iolight.co.uk.
The company says Bovela is the only BVD vaccine available proven to provide 12 months’ protection, against both types of BVD, and after only one shot.
Cattle business manager, Robert Bakewell said: "Provided Bovela is used as recommended on the product label, we are happy to guarantee that it will prevent the birth of PI (persistently infected) calves caused by transplacental infection by the BVD virus.
"We are also encouraging farmers to seek advice and input from their vet about BVD control by offering a £50 voucher towards testing for Bovela users. All herd owners need to do is speak to their veterinary surgeon or email bvdzero.uk@boehringer.com."
BVA President Gudrun Ravetz said: "Veterinary View not only highlights some of the veterinary profession's fantastic work, but complements our joint project with RCVS, Vet Futures, in exploring how the profession can best shape its own future. We hope it will stimulate debate among vets, and the wider community in which we work, about both the big challenges and opportunities that the veterinary profession is facing."
The series includes a number of videos which showcase more recent industry developments:
Stem Cell therapy for the treatment of canine osteoarthritis (VetCell Therapeutics)
Pharmtrax, a mobile device for vets to record work and dispensing on the farm (Henry Schein Animal Health)
Hormone implants as an alternative to castration (Virbac Animal Health)
Practice management support from Zoetis
Preventing an epidemic of equine flu (Merial Animal Health)
BVA has added its voice to the Labelling Matters campaign for the introduction of mandatory method of production labelling of meat and dairy products. This would help consumers across the UK to answer the simple questions "How was this animal kept?" and "Did this animal die a humane death?", including stunning before slaughter.
A key element of the Labelling Matters campaign is that mandatory method of production labelling must be underpinned by robust welfare outcome safeguards, with on-farm welfare assessments ensuring that high welfare standards are being achieved.
Legislation for mandatory method of production labelling has been implemented already for shell eggs, which must legally be labelled either as “eggs from caged hens”, “barn eggs”, “free range” or “organic”. Labelling Matters wants to see this principle extended to meat and dairy products from other farmed animals.
The BVA highlights evidence which shows that consumers in the UK and across Europe want clear food labelling with information about animal welfare:
BVA President Sean Wensley said: "For vets it's a top priority that the animals we rear for food have a good life and a humane death. Research shows that vets are not alone in caring about where their food comes from. Mandatory method of production labelling makes sense on a number of fronts: consumers can be clearly and consistently informed about how the animals reared for their meat and dairy products were kept, with on-farm welfare assessments assuring high standards. Mandatory method of production labelling would give unambiguous information to the high numbers of consumers who care about animal welfare when buying meat and dairy products and help ensure market support for British farmers who pride themselves on achieving the highest welfare standards."
Cefshot is indicated for treatment of subclinical mastitis at drying off with action against Gram positive and Gram negative bacteria.
Jude Roberts MRCVS from Zoetis says this makes possible three-way selective dry cow therapy with products from the company's dry cow portfolio: "With evidence-based triage, this covers teat sealant solo, in combination with narrow spectrum cloxacillin, or now with broader spectrum long-acting cephalonium.
"This is in keeping with the trend from milk buyers for increasing precision in the use of antibiotic dry cow therapy, and only when it is justified in the first place."
Dry periods longer that 54 days require milk withhold for 96 hours. For shorter dry periods, milk withhold is 58 days. Meat withhold period is 21 days.
Cefshot is available in multiples of 24 and 120 tubes, for delivery September onwards.
SRD remains a significant problem for the swine industry1. Associated production losses include 30-70% morbidity, a mortality rate of 4-6% (and even higher in severely affected units), decreased feed efficiency and reduced growth rates2.
Zactran contains gamithromycin. Merial says this bactericidal azalide rapidly accumulates in target lung tissue in less than 30 minutes, where it reaches and exceeds the MBC* for SRD pathogens for an extended period, helping to relieve clinical signs and minimise lung damage.
Zactran has a dose rate of 1ml per 25kg in pigs, administered by intramuscular injection.
The product is available in three pack sizes: 50ml glass bottle and 100ml and 250ml polypropylene shock-resistant bottles, and has a 3 year shelf-life.
References
*MBC: Minimum Bactericidal Concentrations. MBC is the lowest concentration of drug which reduces bacterial counts by 99.9% (CVMP/627/01)
Each week, the email will cover a different topic concerning either dairy, beef, sheep, pigs, poultry or gamebirds. The information, which is personalised with the practice details, can then be forwarded to clients who have an interest in that particular area, for example a resource on mastitis could be sent to dairy farmers and their staff.
Mike Howe, Veterinary Director at NADIS said: "We are confident that practices will recognise the value of the NADIS material and utilise this free service, as it will not only help to raise disease awareness, but will also assist vets in encouraging farmers to think about optimising their herd health. All NADIS materials promote veterinary health planning as the most effective way of preventing disease, and promote the vet’s role on the farm."
The resources also offer an opportunity for farmers and their staff to gain a City & Guilds unit of accreditation. A module can be completed by passing all the quizzes from each disease resource, providing an easy and flexible way for farmers and farm employees to gain recognised qualifications.
For more information, visit: www.nadis.org.uk.
Metacam 40 mg/ml solution for injection for cattle and horses contains 40 mg/ml of meloxicam, and is available in either 50 ml or 100 ml presentations. It is approved for subcutaneous or intravenous use in cattle, and intravenous use in horses.
Boehringer says the introduction comes on the back of a recent large-scale landmark study that found adding Metacam to standard antibiotic therapy for mastitis resulted in a greater first-service conception rate, fewer inseminations required to conceive and a higher probability of pregnancy by 120 days post-calving when compared to cows receiving antibiotic therapy alone1.
Boehringer Ingelheim’s technical manager Kath Aplin said: "By reducing the pain and inflammation caused by mastitis and other conditions, the use of Metacam 40 can result in improvements in cattle health and welfare, and may help limit any reduction in feed intakes. This is central to efficient herd management and productivity."
The company adds that new Metacam 40 mg/ml formulation offers a lower volume dose compared to the existing 20 mg/ml presentation, giving vets more flexibility in their use of Metacam.
James Hutchings, Head of Sales for Bimeda UK, said: "The launch of Tetroxy Vet highlights our ongoing commitment to providing UK veterinarians with a choice of high quality veterinary pharmaceuticals at a fair price."
Bimeda says the benefits of Tetroxy Vet include:
Tetroxy Vet is available in a 100ml pack size.
Velactis (cabergoline) is a POM marketed by Ceva Animal Health, used in the herd management programme of dairy cows as an aid in abrupt drying-off, by reducing milk production.
The product was authorised through the European Medicines Agency (EMA) in December 2015 and was first sold in the UK in April 2016.
The VMD says it has been made aware of reports of serious adverse events, predominantly occurring in Denmark, involving recumbency (lying down and unable to rise) and some deaths. Most adverse events occurred within 8 to 24 hours following product administration. Anecdotal evidence suggests that hypocalcaemia treatments may be successful in reversing clinical signs.
Ceva has decided to stop further distribution of the product in Europe voluntarily, pending the outcome of further investigations to assess a possible causal link between the product and the adverse events reported.
The VMD, EMA, other agencies throughout Europe and the MAH are working closely to monitor the situation.
The VMD highlights that due to the nature and use of the product there is no risk to human health or consumer safety.
Vets and dairy farmers are strongly encouraged to report any adverse events associated with use of Velactis to the VMD using its online reporting form or directly to Ceva for further investigation by the MAH as necessary.
At the start of June, the British Veterinary Association (BVA), British Cattle Veterinary Association (BCVA), Goat Veterinary Society (GVS), and Sheep Veterinary Society (SVS) welcomed the announcement that bluetongue (BTV-8) vaccine would be available by mid-July to support farmers and smallholders in managing the risk of a bluetongue outbreak predicted to reach mainland UK by late summer.
Since the Defra risk assessment indicates a high risk by late summer of a BTV incursion from France, veterinary associations have been involved in discussions with government, farmers’ representatives and manufacturers to ensure vaccine is available to meet potential demand particularly in the south of England where risk is highest. The situation remains under constant review by Defra as the disease develops and the weather warms up, promoting midge activity.
Pharmaceutical companies MSD and Zoetis announced that batches of vaccine would be available from mid-July, which Defra has just confirmed.
Vets across the UK are also contributing to the Joint campaign Against Bluetongue (JAB), helping to make farmers aware of the risk, clinical signs and what action to take, through speaking at local JAB information events and displaying posters and leaflets in practices.
While welcoming the announcement of vaccine availability in June, veterinary organisations also sought clarification about the cost and the amount of vaccine likely to be available in July and thereafter. This information is now available.
BVA President Sean Wensley said: "We welcome the announcement that vaccine will be available in time to meet potential demand. This disease seriously affects animal health and welfare as well as the productivity of livestock, and vaccination is the key control."
Photo by Fourrure (http://www.boulesdefourrure.fr) [CC BY-SA 2.0], via Wikimedia Commons
The new 10ml (10-dose) and 100ml (100-dose) packs of Ingelvac PRRS EU are available now, and will complement the existing 50ml (50-dose) packs.
Callum Blair MRCVS, Swine Brand Manager at Boehringer Ingelheim, said: "Nobody likes to end up with part used bottles of any vaccine that then have to be discarded. The addition of Ingelvac PRRS EU 10-dose and 100-dose packs will provide choice for different sized units and help reduce wasted doses."
For more information, visit www.prrs.com.
During the 60 days before to 30 days after calving, dairy cows experience a dip in their natural immunity, leaving them especially vulnerable to important diseases such as mastitis2, metritis3 and retained placenta.4 With serious cost consequences and implications for cow welfare and productivity, this makes the transition period one of the most challenging yet vital periods for vets to manage with dairy clients.
Imrestor (pegbovigrastim injection) is a pegylated form of the naturally occurring protein cytokine, bovine Granulocyte Colony Stimulating Factor (bG-CSF). Elanco says it helps restore the cow’s natural defences by increasing the number and restoring the function of neutrophils, the primary type of white blood cell that recognizes and kills harmful bacteria.
Fiona Anderson, Technical Vet at Elanco, said: "It’s no secret that a successful transition period is vital for maximising productivity in the next lactation, yet we are still ‘firefighting’ common transition diseases like mastitis rather than focusing on their true cause."
"Vets are under increasing pressure to adopt a more proactive approach, not least to reduce the use of antibiotics in livestock but with few credible alternatives. This can be challenging in dairy herds, particularly around calving when cows are susceptible to multiple disease challenges while their defences are low. Imrestor helps to restore a cow’s own natural immunity and strengthen her ability to defend against infection by a range of mastitis pathogens – thus helping to protect the cow against mastitis when she needs it most."
Available in pre-filled, single-dose syringes, Imrestor is administered with two injections – one seven days prior to the anticipated date of calving and the other within 24 hours after calving – with neither injection requiring a withdrawal period.
Kingsley Baxendale, Ruminant Marketing Manager at Elanco Animal Health said: "It can be extremely frustrating for vets to see their dairy farmers struggling with the stress and hassle of dealing with increased numbers of sick cows during calving; they have enough to deal with at the moment. We’re delighted that Imrestor can provide vets with a tool to help decrease the negative consequences associated with immune-related diseases like mastitis and maximise their herds’ lactation potential."
As part of the launch of Imrestor, Elanco also announced its new 'Pledge To Protect' initiative to encourage vets and farmers to make a pledge symbolising their commitment to address immune suppression in their dairy cows.
The number of pledges will be tracked using a life-sized 2D cow model, pictured above. For each pledge, which can be made online or at events, Elanco will make a £5 donation to The Royal Agricultural Benevolent Institution (R.A.B.I), which supports farmers in difficulty. As a thank you for showing support, all pledgers will automatically be entered into a weekly prize draw.
To find out more about using Imrestor and how you can make your pledge, visit www.vital90days.co.uk.
Bovalto Respi vaccines contain a newly developed combination of viral and bacterial antigens. Merial says the recent vaccine isolates effectively target current European-circulating Bovine Respiratory Disease (BRD) strains. Bovalto antigens are also proven by challenge, including at six months post-vaccination to confirm long-lasting protection.
Henry Berger, Global Head of the Ruminant and Equine Business Unit at Merial, said: "Merial is committed to understanding the needs of cattle producers and delivering unique, targeted solutions. Merial is dedicated to expanding its portfolio of parasiticides, vaccines and other disease prevention solutions, with high-value products like Bovalto Respi, to improve productivity, and keep herds healthy."
Merial highlights that BRD is complex to manage and each year affects an estimated 1.9 million animals1, costing the UK cattle industry around £60 million2. In Ireland BRD is responsible for 30% of deaths in stock under one-year old3.
At a Merial symposium at WBC 2016, Prof. Sandro Cavirani, Director of the Department of Animal Health at the University of Parma, Italy highlighted the importance of successful BRD control programmes in calves to optimise herd immunity and productivity, including early, repeated and targeted BRD vaccination.
Bovalto Respi 3 contains strains of Parainfluenza Virus 3, Bovine Respiratory Syncytial Virus, and Mannheimia haemolytica serotype A1. The combination in Bovalto Respi 4 combines the three pathogens in Bovalto Respi 3, with the added strain of Bovine Viral Diarrhoea Virus (BVDV).